Tianci International Seeks Shareholder Approval for Massive Dilution, Reverse Split, and Deeply Discounted CEO-Related Preferred Stock Sale

summarizeSummary

Tianci International is seeking shareholder approval for a significant increase in authorized shares, a reverse stock split to avoid delisting, and a highly dilutive, deeply discounted preferred stock sale to an entity controlled by its CEO.

check_boxKey Events · Financing and Capital Events · CIIT

• Massive Increase in Authorized Shares Proposed

  Shareholders are asked to approve an amendment to increase authorized common stock from 100 million to 2 billion shares, providing the company with significant capacity for future equity financing and potential dilution.

• Reverse Stock Split to Avoid Delisting

  The company seeks approval for a reverse stock split, with a ratio between 1-for-2 and 1-for-100, to regain compliance with Nasdaq's $1.00 minimum bid price requirement and avoid delisting.

• Deeply Discounted Preferred Stock Sale to CEO's Entity

  A proposal to sell 30,000 Series C Preferred Shares to RQS Capital, controlled by CEO Shufang Gao, for $30,000. These shares are convertible into 3 million common shares, representing approximately 10.89% dilution at an effective price of $0.01 per common share, a substantial discount to the current market price of $0.3565.

• Increased CEO Control and Potential Nasdaq Equity Rule Violation

  The preferred stock sale would increase CEO Shufang Gao's voting control from 57.68% to 62.29% and the implicit compensation value of $1.07 million could cause shareholder equity to fall below Nasdaq's minimum requirement, risking further delisting.

auto_awesomeAnalysis · CIIT · Technology

Tianci International's definitive proxy statement outlines several critical proposals that collectively signal significant financial distress and potential shareholder dilution. The proposed increase in authorized common shares by 20-fold, from 100 million to 2 billion, provides the board with immense flexibility for future equity financing, which could lead to substantial dilution for existing shareholders. Concurrently, the company is seeking approval for a reverse stock split (up to 1-for-100) to regain compliance with Nasdaq's minimum bid price requirement, indicating a struggle to maintain its listing. Most notably, the proposal to sell 30,000 shares of Series C Preferred Stock to RQS Capital, an entity controlled by CEO Shufang Gao, for a mere $30,000 is highly concerning. These preferred shares are convertible into 3 million common shares, representing approximately 10.89% dilution at an effective price of $0.01 per common share equivalent, a deep discount to the current market price of $0.3565. This related-party transaction significantly increases the CEO's voting control and the substantial compensation expense it represents could cause shareholder equity to fall below Nasdaq's minimum requirement, risking further delisting. Investors should be aware of the severe dilutive potential and the implications of these proposals on shareholder value and corporate governance.